Item no. |
TRC-B682600-100mg |
Manufacturer |
Toronto Research Chemicals
|
CASRN |
22260-51-1 |
Amount |
100 mg |
Quantity options |
100 mg
10 mg
250 mg
25 mg
500 mg
50 mg
|
Category |
|
Type |
Biochemicals |
Specific against |
other |
Purity |
>95% (HPLC) |
InCHI |
1S/C32H40BrN5O5.CH4O3S/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18;1-5(2,3)4/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39);1H3,(H,2,3,4)/t18-, |
Smiles |
CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C.CS(=O)(=O)O |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Bromocriptine mesilate, (6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide monomethanesulfonate, Ergocryptine, 2-bromo-, monomethanesulfonate (salt) (8CI), 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv., Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv., (+)-Bromocriptine methanesulfonate, Bagren, Bromocriptine mesylate, Bromocriptine methanesulfonate, Bromocryptine mesylate, Bromocryptine methanesulfonate, CB 154, Cycloset, Parlodel, Pravidel, Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5alpha)-, methanesulfonate (1:1), Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-, monomethanesulfonate (salt) (9CI) |
Shipping condition |
Room temperature |
Hazard information |
Shipping Info: Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package | Air Forbidden: False | Controlled Products: Not Controlled | Hazardous Class: Suspected of damaging fertility or the unborn child | UN #: UN3077 | IATA Regulations: 9 | Packing Group: III |
Available |
|
Manufacturer - Category |
Impurity standards; Additional pharmaceutical toxicology reference materials; Enzyme inhibitors; Alkaloids; Additional pharmaceutical toxicology research materials; Dopamine receptors; Addiction; Alzheimer's; Depression; Huntington's; Neurotransmission; Parkinson's; Schizophrenia; Stress and Anxiety; Pain and Inflammation; Additional toxicology reference materials; Neurological diseases (Alzheimer's, Parkinson's, Dementia) |
Country of Origin |
Canada |
Shipping Temperature |
RT|Room Temperature |
Storage Conditions |
-20°C |
Molecular Weight |
750, 7 |
Shipping Info |
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
Air Forbidden |
False |
Controlled Products |
Not Controlled |
MSDS Availability |
TRUE |
Hazardous Class |
Suspected of damaging fertility or the unborn child |
UN # |
UN3077 |
IUPAC |
(6aR, 9R)-5-Bromo-N-[(2R, 5S, 10aS, 10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3, 6-dioxooctahydro-8H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl]-7-methyl-4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinoline-9-carboxamide methanesulfonate |
IATA Regulations |
9 |
Packing Group |
III |
Manufacturer - Synonym |
Bromocriptine mesilate, (6aR, 9R)-5-Bromo-N-[(2R, 5S, 10aS, 10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3, 6-dioxooctahydro-8H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl]-7-methyl-4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinoline-9-carboxamide monomethanesulfonate, Ergocryptine, 2-bromo-, monomethanesulfonate (salt) (8CI), 8H-Oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazine, ergotaman-3', 6', 18-trione deriv., Indolo[4, 3-fg]quinoline, ergotaman-3', 6', 18-trione deriv., (+)-Bromocriptine methanesulfonate, Bagren, Bromocriptine mesylate, Bromocriptine methanesulfonate, Bromocryptine mesylate, Bromocryptine methanesulfonate, CB 154, Cycloset, Parlodel, Pravidel, Ergotaman-3', 6', 18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5alpha)-, methanesulfonate (1:1), Ergotaman-3', 6', 18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-, monomethanesulfonate (salt) (9CI) |